In the last trading session, 1.68 million BioAtla Inc (NASDAQ:BCAB) shares changed hands as the company’s beta touched 1.15. With the company’s per share price at $0.34 changed hands at -$0.04 or -10.55% during last session, the market valuation stood at $19.73M. BCAB’s last price was a discount, traded about -1082.35% off its 52-week high of $4.02. The share price had its 52-week low at $0.38, which suggests the last value was -11.76% down since then.
Analysts gave the BioAtla Inc (BCAB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended BCAB as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. BioAtla Inc’s EPS for the current quarter is expected to be -0.38.
BioAtla Inc (NASDAQ:BCAB) trade information
Instantly BCAB was in red as seen at the end of in last trading. With action -27.41%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -42.47%, with the 5-day performance at -27.41% in the red. However, in the 30-day time frame, BioAtla Inc (NASDAQ:BCAB) is -31.93% down.
The consensus price target for the stock as assigned by Wall Street analysts is 5, meaning bulls need an upside of 93.2% from its current market value. According to analyst projections, BCAB’s forecast low is 5 with 5 as the target high. To hit the forecast high, the stock’s price needs a -1370.59% plunge from its current level, while the stock would need to soar -1370.59% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -25.30%. The 2025 estimates are for BioAtla Inc earnings to increase by 40.93%, but the outlook for the next 5-year period is at 18.02% per year.
BCAB Dividends
BioAtla Inc is expected to release its next quarterly earnings report in March.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.9205% or 1.89 million shares worth $2.58 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . With 1.27 shares estimated at $0.43 million under it, the former controlled 2.63% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 1.14% of the shares, roughly 549.45 shares worth around $0.19 million.
